These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 11020964

  • 1. Immunoserological aspects of idiopathic inflammatory muscle disease.
    Rozman B, Bozic B, Kos-Golja M, Plesivcnik-Novljan M, Kveder T.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):722-7. PubMed ID: 11020964
    [Abstract] [Full Text] [Related]

  • 2. Clinical implications of autoantibody screening in patients with autoimmune myositis.
    Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Bendo R, Briani C, Rondinone R, Sarzi-Puttini P, Todesco S, Doria A.
    Autoimmunity; 2006 May 25; 39(3):217-21. PubMed ID: 16769655
    [Abstract] [Full Text] [Related]

  • 3. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M, Hausmann-Martinez-Pardo G, Braun-Falco O.
    Hautarzt; 1989 Oct 25; 40(10):623-9. PubMed ID: 2482267
    [Abstract] [Full Text] [Related]

  • 4. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
    Rönnelid J, Barbasso Helmers S, Storfors H, Grip K, Rönnblom L, Franck-Larsson K, Nordmark G, Lundberg IE.
    Autoimmun Rev; 2009 Sep 25; 9(1):58-61. PubMed ID: 19285154
    [Abstract] [Full Text] [Related]

  • 5. Immune manifestations of inflammatory muscle disease.
    Targoff IN.
    Rheum Dis Clin North Am; 1994 Nov 25; 20(4):857-80. PubMed ID: 7855326
    [Abstract] [Full Text] [Related]

  • 6. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
    Schilders G, Egberts WV, Raijmakers R, Pruijn GJ.
    Arthritis Rheum; 2007 Jul 25; 56(7):2449-54. PubMed ID: 17599775
    [Abstract] [Full Text] [Related]

  • 7. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
    Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV.
    Arthritis Rheum; 2004 Jan 25; 50(1):209-15. PubMed ID: 14730618
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
    Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senécal JL.
    Arthritis Res Ther; 2007 Jan 25; 9(4):R78. PubMed ID: 17688695
    [Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen.
    Mahler M, Raijmakers R, Dähnrich C, Blüthner M, Fritzler MJ.
    Arthritis Res Ther; 2005 Jan 25; 7(3):R704-13. PubMed ID: 15899056
    [Abstract] [Full Text] [Related]

  • 10. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
    Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M.
    J Rheumatol; 1984 Oct 25; 11(5):663-5. PubMed ID: 6334746
    [Abstract] [Full Text] [Related]

  • 11. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P, Dwivedi S, Misra R.
    Rheumatol Int; 2016 Jul 25; 36(7):935-43. PubMed ID: 27193471
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
    Feldman BM, Reichlin M, Laxer RM, Targoff IN, Stein LD, Silverman ED.
    J Rheumatol; 1996 Oct 25; 23(10):1794-7. PubMed ID: 8895161
    [Abstract] [Full Text] [Related]

  • 13. Autoantibody profiles in the sera of European patients with myositis.
    Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, Grøndal G, Hietarinta M, Isenberg D, Kalden JR, Lundberg I, Moutsopoulos H, Roux-Lombard P, Vencovsky J, Wikman A, Seelig HP, van Engelen BG, van Venrooij WJ.
    Ann Rheum Dis; 2001 Feb 25; 60(2):116-23. PubMed ID: 11156543
    [Abstract] [Full Text] [Related]

  • 14. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
    Mahler M, Raijmakers R.
    Autoimmun Rev; 2007 Aug 25; 6(7):432-7. PubMed ID: 17643929
    [Abstract] [Full Text] [Related]

  • 15. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
    Schnitz W, Taylor-Albert E, Targoff IN, Reichlin M, Scofield RH.
    J Rheumatol; 1996 Oct 25; 23(10):1729-33. PubMed ID: 8895149
    [Abstract] [Full Text] [Related]

  • 16. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
    Sarkar K, Weinberg CR, Oddis CV, Medsger TA, Plotz PH, Reveille JD, Arnett FC, Targoff IN, Genth E, Love LA, Miller FW.
    Arthritis Rheum; 2005 Aug 25; 52(8):2433-8. PubMed ID: 16052581
    [Abstract] [Full Text] [Related]

  • 17. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
    Hengstman GJ, Brouwer R, Egberts WT, Seelig HP, Jongen PJ, van Venrooij WJ, van Engelen BG.
    J Neurol; 2002 Jan 25; 249(1):69-75. PubMed ID: 11954871
    [Abstract] [Full Text] [Related]

  • 18. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen.
    Hengstman GJ, Vree Egberts WT, Seelig HP, Lundberg IE, Moutsopoulos HM, Doria A, Mosca M, Vencovsky J, van Venrooij WJ, van Engelen BG.
    Ann Rheum Dis; 2006 Feb 25; 65(2):242-5. PubMed ID: 16410528
    [Abstract] [Full Text] [Related]

  • 19. Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein.
    Espada G, Maldonado Cocco JA, Fertig N, Oddis CV.
    J Rheumatol; 2009 Nov 25; 36(11):2547-51. PubMed ID: 19833756
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.